Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
Learn more on Edimer website.
Other news
News
09/04/19 Focus on...
Ichthyosis Awareness Month 2019 : more than ever needed